These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Update on digoxin therapy in congestive heart failure. Haji SA; Movahed A Am Fam Physician; 2000 Jul; 62(2):409-16. PubMed ID: 10929703 [TBL] [Abstract][Full Text] [Related]
4. Neurohormones and heart failure. Mendzef SD; Slovinski JR Nurs Clin North Am; 2004 Dec; 39(4):845-61. PubMed ID: 15561165 [TBL] [Abstract][Full Text] [Related]
5. The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications. Triposkiadis F; Karayannis G; Giamouzis G; Skoularigis J; Louridas G; Butler J J Am Coll Cardiol; 2009 Nov; 54(19):1747-62. PubMed ID: 19874988 [TBL] [Abstract][Full Text] [Related]
6. Neurohormonal activation in congestive heart failure and the role of vasopressin. Chatterjee K Am J Cardiol; 2005 May; 95(9A):8B-13B. PubMed ID: 15847852 [TBL] [Abstract][Full Text] [Related]
7. Evidence for the survival benefit of neurohormonal antagonists in the management of geriatric congestive heart failure. Firdaus M; Bukhari N J Okla State Med Assoc; 2003 Mar; 96(3):133-9. PubMed ID: 12688226 [TBL] [Abstract][Full Text] [Related]
8. Cardioprotection by aldosterone receptor antagonism in heart failure. Part I. The role of aldosterone in heart failure. Dieterich HA; Wendt C; Saborowski F Fiziol Cheloveka; 2005; 31(6):97-105. PubMed ID: 16366159 [TBL] [Abstract][Full Text] [Related]
11. Compensatory changes of sympathetic tone, the renin-angiotensin-aldosterone system, vasopressin, and ANF as potential therapeutic targets in congestive heart failure. van Zwieten PA Z Kardiol; 1988; 77 Suppl 5():67-76. PubMed ID: 2975894 [TBL] [Abstract][Full Text] [Related]
12. Congestive heart failure: guidelines for the primary care physician. Galin I; Baran DA Mt Sinai J Med; 2003 Sep; 70(4):251-64. PubMed ID: 12968198 [TBL] [Abstract][Full Text] [Related]
13. Economic implications of treatment guidelines for congestive heart failure. Shibata MC; Nilsson C; Hervas-Malo M; Jacobs P; Tsuyuki RT Can J Cardiol; 2005 Dec; 21(14):1301-6. PubMed ID: 16341301 [TBL] [Abstract][Full Text] [Related]
14. [Neurohormonal compensation processes in chronic heart failure: the effect of drugs]. van Zwieten PA; Lie KI Ned Tijdschr Geneeskd; 1994 Jun; 138(24):1208-13. PubMed ID: 7912411 [No Abstract] [Full Text] [Related]
15. Use of beta-blockers in chronic congestive heart failure. Mahanonda N; Samranthin M; Panyarachun S J Med Assoc Thai; 2000 Oct; 83(10):1240-7. PubMed ID: 11143491 [TBL] [Abstract][Full Text] [Related]
17. The effect of neurohormonal antagonists in reducing heart failure hospitalizations. Williams RE Curr Med Res Opin; 2006 Jan; 22(1):139-50. PubMed ID: 16393440 [TBL] [Abstract][Full Text] [Related]
18. Mechanisms of neurohormonal activation in chronic congestive heart failure: pathophysiology and therapeutic implications. Dávila DF; Núñez TJ; Odreman R; de Dávila CA Int J Cardiol; 2005 Jun; 101(3):343-6. PubMed ID: 15907399 [TBL] [Abstract][Full Text] [Related]
19. Pathophysiology and clinical spectrum of acute congestive heart failure. Shah M; Ali V; Lamba S; Abraham WT Rev Cardiovasc Med; 2001; 2 Suppl 2():S2-6. PubMed ID: 12439355 [TBL] [Abstract][Full Text] [Related]
20. Pharmacological treatment of congestive heart failure in Canada: a description of care in five provinces. Cox JL; Ramer SA; Lee DS; Humphries K; Pilote L; Svenson L; Tu JV; Can J Cardiol; 2005 Mar; 21(4):337-43. PubMed ID: 15838560 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]